Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HL201 is a topical live biotherapeutic product (LBP) being developed by Shenzhen 01 Life Technology (01Life) for the treatment of hair loss (alopecia). As a microbiome-based therapy, it is designed to modulate the scalp microbiome to address the underlying factors of hair loss. The specific bacterial composition and molecular targets of HL201 have not been publicly disclosed. The product is currently in the IND-enabling phase of development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HL201.